首 页
医药产品
医保药品
中标目录
医药招标
数据中心
医学资料
医药新闻
医药展会
OTC药品
保健品
医疗器械
处方药
专科药
中医药
器械中标目录
药品批发行情
求购信息
医药下载
药价简讯
当前位置:药药网 / 数据中心 / 临床注释-2,变异和临床注释数据
庆大霉素
临床注释ID
1451434860
药物名称(英)
gentamicin
变异单倍型
rs267606617
基因
MT-ND1;MT-RNR1
证据级别
1A
水平覆盖
水平修饰符
Rare Variant; Tier 1 VIP
表现型类别(英)
Toxicity
表现型类别
毒性
分数
108
PMID计数
28
计数的证据
29
表现型
耳毒性
表现型(英)
Ototoxicity
最新日期
2021/6/15 0:00:00
URL
https://www.pharmgkb.org/clinicalAnnotation/1451434860
专业人口(英)
Pediatric
专业人口
儿科
临床等位基因
id
等位基因
注释文本
671
G
The rs267606617 G allele (also known as the 1555G allele) is assigned as a MT-RNR1 increased risk of aminoglycoside-induced hearing loss allele by CPIC. Patients with the G allele may have an increased risk of experiencing hearing loss when treated with gentamicin as compared to patients with the A allele. However, conflicting evidence has been reported. MT-RNR1 is a mitochondrial gene and is inherited as a haploid (i.e. there is only ever one allele present). Other genetic and clinical factors may also influence risk of hearing loss when treated with gentamicin.
670
A
The rs267606617 A allele (also known as the 1555A allele) is assigned as a MT-RNR1 normal risk of aminoglycoside-induced hearing loss allele by CPIC. Patients with the A allele may have a decreased, but not absent, risk of experiencing hearing loss when treated with gentamicin as compared to patients with the G allele. However, conflicting evidence has been reported. MT-RNR1 is a mitochondrial gene and is inherited as a haploid (i.e. there is only ever one allele present). Other genetic and clinical factors may also influence risk of hearing loss when treated with gentamicin.
临床证据
id
证据的ID
总结
1068
1444697639
Allele G is associated with increased risk of Ototoxicity when treated with gentamicin in infants as compared to allele A.
1067
1449732298
Allele G is associated with Ototoxicity when treated with aminoglycoside antibacterials or gentamicin as compared to allele A.
1066
1444696940
Allele G is associated with Ototoxicity when treated with gentamicin, kanamycin or streptomycin as compared to allele A.
1065
1444697282
Allele G is associated with Ototoxicity when treated with aminoglycoside antibacterials or gentamicin as compared to allele A.
1064
1184510153
Allele G is associated with Ototoxicity when treated with aminoglycoside antibacterials, gentamicin, kanamycin or streptomycin in children as compared to allele A.
1063
1444697353
Allele G is associated with Ototoxicity when treated with gentamicin or streptomycin in children with as compared to allele A.
1062
PA166229081
Annotation of CPIC Guideline for amikacin, gentamicin, kanamycin, paromomycin, plazomicin, streptomycin, tobramycin and MT-RNR1
645
1451440143
Allele G is associated with increased risk of Ototoxicity when treated with gentamicin.
644
1451440094
Allele G is associated with increased risk of Ototoxicity when treated with gentamicin.
643
1451438424
Allele G is associated with increased risk of Ototoxicity when treated with aminoglycoside antibacterials, gentamicin, kanamycin or streptomycin.
642
1451437860
Allele G is associated with increased affinity to MT-RNR1 of gentamicin, kanamycin, neomycin, paromomycin, streptomycin or tobramycin.
641
1451437800
Allele G is associated with increased risk of Ototoxicity when treated with aminoglycoside antibacterials, gentamicin or streptomycin.
640
1451437709
Allele G is associated with increased risk of Ototoxicity due to gentamicin.
639
1451437580
Allele G is associated with increased risk of Ototoxicity when treated with aminoglycoside antibacterials, gentamicin, kanamycin or streptomycin.
638
1451436400
Allele G is associated with increased affinity to MT-RNR1 of gentamicin, hygromycin b, kanamycin, neomycin, paromomycin or tobramycin.
637
1444697006
Allele G is associated with Ototoxicity when treated with amikacin, gentamicin, kanamycin, neomycin or streptomycin as compared to allele A.
636
1444697622
Allele G is associated with Ototoxicity when treated with amikacin, gentamicin or tobramycin in children with Cystic Fibrosis as compared to allele A.
635
1444697495
Allele G is associated with Ototoxicity when treated with aminoglycoside antibacterials or gentamicin as compared to allele A.
634
1444697463
Allele G is not associated with Ototoxicity when treated with gentamicin in infants as compared to allele A.
633
1444697449
Allele G is associated with Ototoxicity when treated with gentamicin in infants as compared to allele A.
632
1444697442
Allele G is associated with Ototoxicity when treated with amikacin, gentamicin or streptomycin as compared to allele A.
631
1444697293
Allele G is associated with Ototoxicity when treated with gentamicin or streptomycin as compared to allele A.
630
1444697250
Allele G is associated with Ototoxicity when treated with gentamicin or streptomycin as compared to allele A.
629
1444697241
Allele G is associated with Ototoxicity when treated with aminoglycoside antibacterials, gentamicin or streptomycin as compared to allele A.
628
1444697228
Allele G is associated with Ototoxicity when treated with aminoglycoside antibacterials, gentamicin or streptomycin as compared to allele A.
627
1444697188
Allele G is associated with Ototoxicity when treated with gentamicin, kanamycin or streptomycin as compared to allele A.
626
1444697155
Allele G is associated with Ototoxicity when treated with gentamicin, kanamycin or streptomycin as compared to allele A.
625
1444697136
Allele G is associated with Ototoxicity when treated with aminoglycoside antibacterials, gentamicin, kanamycin or streptomycin as compared to allele A.
624
1444697089
Allele G is associated with Ototoxicity when treated with aminoglycoside antibacterials or gentamicin as compared to allele A.
临床病史
id
类型
评论
918
Update
Corrected typo
917
Update
Added CPIC guideline to evidence and edited phenotype descriptions
916
Update
Added PMID 26497601 to evidence
915
Update
Added PMID 24252789 to evidence
914
Update
Added PMID 21205314 to evidence
913
Update
Added PMID 19687236 to evidence
912
Update
Added PMID 18386806 to evidence
911
Update
Added PMID 17723226 to evidence
910
Update
Added PMID 16152638 to evidence
909
Update
Added PMID 9315872 to evidence
908
Note
Checked by second curator before approval
907
Create
Created
最新招商产品
更多>>
韩特润目冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特润目冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特乳康冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨冷敷凝胶贴牌定制代..
济南康民药业..
全国||不限
韩特筋骨医用冷敷贴贴牌定制..
济南康民药业..
全国||不限
韩特筋骨医用冷敷贴贴牌定制..
济南康民药业..
全国||不限
韩特前列腺冷敷凝胶贴牌定制..
济南康民药业..
全国||不限
韩特前列腺医用冷敷贴贴牌定..
济南康民药业..
全国||不限
网站地图
-
网站开发
-
网站简介
-
会员服务
-
法律声明
-
联系我们
-
药品招商频道
-
药品信息排行
-
2018年版国家基本药物目录
-
意见反馈
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:
医药研究数据
|
医药资料
|
SDA药品评审中心
|
中医网
|
中药处方系统
|
爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究 客服热线:0575-83552251 / 13754370441 QQ客服:
浙ICP备16010490号-2
增值电信业务经营许可证:
浙B2-20220931
互联网药品信息服务资格证书编号:
(浙)-经营性2023-0215
浙公网安备:330683240604819103159
医药代理商群1:
医药代理商群2:
医药代理商群3: